Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Semaglutide for Preservation of Beta Cell Function and Restoration of Alpha Cell Function

NCT07430332 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT07430332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07430332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Semaglutide for Preservation of Beta Cell Function and Restoration of Alpha Cell Function
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2027
Completion date
January 1, 2030
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage 1 diabetes mellitus, type 1